Lion Point Capital, LP: summary

Lion Point Capital, LP reported 35 positions with a reported value of $20.91M in its 13F for Q2 2026. Compared with Q1 2026: 1 new positions, 1 exited.

Top positions

• CUE BIOPHARMA INC
• Praxis Precision Medicines Inc
• MOONLAKE IMMUNOTHERAPEUTICS
• Fennec Pharmaceuticals Inc
• ROYALTY PHARMA PLC- CL A
• COMPASS PATHWAYS PLC SPONSORED ADS
• MILESTONE PHARMACEUTICALS IN
• Benitec Biopharma Inc
• Syndax Pharmaceuticals Inc
• BIOHAVEN LTD